Last news
Accro Bioscience Announces IND Clearance from NMPA for Phase II/III Clinical Trial of AC-201, a Highly Selective TYK2/JAK1 Inhibitor for the Treatment of Non-Segmental Vitiligo

Accro Bioscience Announces IND Clearance from NMPA for Phase II/III Clinical Trial of AC-201, a Highly Selective TYK2/JAK1 Inhibitor for the Treatment of Non-Segmental Vitiligo

NEW YORK and SUZHOU, China, Sept. 8, 2026 /PRNewswire/ -- Accro Bioscience (Suzhou) Limited ("Accro") today announced that Shanghai Fosun Pharmaceutical Industrial Development Company Limited ("Fosun Pharma Industrial"), a subsidiary of its partner...

HBM9378/WIN378, an Ultra-Long-Acting Antibody Targeting TSLP, Achieves Positive Phase 2 Results in Asthma and Initiates Phase 3 Study

HBM9378/WIN378, an Ultra-Long-Acting Antibody Targeting TSLP, Achieves Positive Phase 2 Results in Asthma and Initiates Phase 3 Study

The POLARIS-1 study enrolled 147 patients with uncontrolled, moderate-to-severe asthma, and the interim analysis was conducted on the first 98 patients. The analysis demonstrated a half-life of up to 75 days, with clinical effects consistent with...

Alebund Pharmaceuticals Announces FDA Clearance of IND Application for AP308 for the Treatment of IgA Nephropathy

Alebund Pharmaceuticals Announces FDA Clearance of IND Application for AP308 for the Treatment of IgA Nephropathy

SHANGHAI, Sept. 8, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, today announced that it has recently received clearance from the U.S. Food and...

Kelun-Biotech's Partner Windward Bio Announces Positive Phase 2 Results of SKB378/WIN378 in Asthma, and Initiates Phase 3 Study

Kelun-Biotech's Partner Windward Bio Announces Positive Phase 2 Results of SKB378/WIN378 in Asthma, and Initiates Phase 3 Study

The POLARIS-1 study enrolled 147 patients with uncontrolled, moderate-to-severe asthma, and the interim analysis was conducted on the first 98 patients. The analysis demonstrated a half-life of up to 75 days, with clinical effects consistent with...

Axcelis to Build New Manufacturing Facility in Pyeongtaek, Korea

Axcelis to Build New Manufacturing Facility in Pyeongtaek, Korea

BEVERLY, Mass., Sept. 8, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced plans to invest $35 million in its global...

CDF Corporation Launches the Squiz® System in North America, Bringing Automated Liner Evacuation to Manufacturers of Thick, High-Value Liquids

CDF Corporation Launches the Squiz® System in North America, Bringing Automated Liner Evacuation to Manufacturers of Thick, High-Value Liquids

New automated system recovers high-value product left behind in IBC liners, reducing product waste by up to 96 percent in manufacturer trials PLYMOUTH, Mass., Sept. 8, 2026 /PRNewswire/ -- CDF Corporation, a manufacturer of flexible liners for...

Trip.Gourmet Unveils Global 2027 Fine Dining List and Debuts New WOW Privileges Programme

Trip.Gourmet Unveils Global 2027 Fine Dining List and Debuts New WOW Privileges Programme

744 restaurants across 105 cities and 40 countries and regions recognised, as global food search interest accelerates worldwide New WOW Privileges programme launched, giving Black Diamond members exclusive access to scarce seats at hard-to-book...

YYForce Launches Facadevision AI; Automates IFM Division with Drone and AI-Powered Exterior Maintenance

YYForce Launches Facadevision AI; Automates IFM Division with Drone and AI-Powered Exterior Maintenance

70:30 joint venture with Integral Cleaning introduces drone and AI-enabled facade inspection to Singapore's commercial real estate sector, enhancing safety and operational efficiency. SINGAPORE, Sept. 8, 2026 /PRNewswire/ -- YYForce Inc. (NASDAQ:...

1 2 3 4 5 6 7 8 9 10 ... 5419
menu
menu